Expression of mdr1 gene in human breast primary tumors and metastases

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Breast Cancer Research and Treatment

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00665804PMID 8251651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.

  1993cited by this paper
• Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography.

  1992cited by this paper
• Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

  1992cited by this paper
• Expression of the Multidrug Resistance Gene in Human Cancer

  1991cited by this paper
• Oncogene and MDR1 gene expression in rat rhabdomyosarcoma sublines of different metastatic potential.

  1991cited by this paper
• Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine.

  1991cited by this paper
• Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma.

  1991cited by this paper
• Induction of in vitro resistance to 4'-epidoxorubicin and cis-dichlorodiammineplatinum in hepatoma cells.

  1991cited by this paper
• Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.

  1991cited by this paper
• MDR1 gene expression and prognostic factors in primary breast carcinomas.

  1991cited by this paper
• Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis.

  1991cited by this paper
• Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer.

  1990cited by this paper
• Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

  1990cited by this paper
• P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies.

  1990cited by this paper
• Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity.

  1990cited by this paper
• Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.

  1990cited by this paper
• Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance.

  1989cited by this paper
• Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.

  1989cited by this paper
• Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining.

  1989cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.

  1989influential reference
• Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors.

  1989cited by this paper
• Quantitative morphological analysis of adriamycin-resistant human K562 leukemic cells.

  1989cited by this paper
• Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells.

  1989cited by this paper
• Expression of Multidrug Resistance Gene in Human Cancers

  1989cited by this paper
• The multidrug transporter, a double-edged sword.

  1988cited by this paper
• Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.

  1988cited by this paper
• P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer specimens.

  1988cited by this paper
• The cell biology of multiple drug resistance.

  1987cited by this paper
• Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.

  1987cited by this paper
• Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cells.

  1987cited by this paper
• Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.

  1987cited by this paper
• Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.

  1986cited by this paper
• Amplification and expression of genes associated with multidrug resistance in mammalian cells.

  1986cited by this paper
• Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases.

  1984cited by this paper
• Metastatic behavior of an adriamycin-resistant murine tumor.

  1983cited by this paper

• SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma

  2024cites this paper
• Chemoprotection Across the Tumor Border: Cancer Cell Response to Doxorubicin Depends on Stromal Fibroblast Ratios and Interstitial Therapeutic Transport

  2017cites this paper
• Somatostatin Receptor-Mediated Tumor-Targeting Nanocarriers Based on Octreotide-PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy.

  2016cites this paper
• Evaluation of P‐glycoprotein (Pgp) expression in human osteosarcoma by high‐throughput tissue microarray

  2016cites this paper
• CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination

  2015cites this paper
• Smart pH‐Responsive Nanocarriers Based on Nano‐Graphene Oxide for Combined Chemo‐ and Photothermal Therapy Overcoming Drug Resistance

  2014cites this paper
• Potential roles for prions and protein-only inheritance in cancer

  2012cites this paper
• Elevated expression of both MDR1 and MMP-2 genes in metastasized lymph node of invasive ductal breast cancer.

  2012cites this paper
• The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel

  2009cites this paper
• Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.

  2008cites this paper
• Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

  2005cites this paper
• The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer.

  2005cites this paper
• Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells.

  2003cites this paper
• ATP binding cassette transporters and drug resistance in breast cancer.

  2003cites this paper
• Modulation of HLA class I expression in multidrug-resistant human rhabdomyosarcoma cells.

  2003cites this paper
• Endocrine-Related Cancer ( 2003 ) 10 43 – 73 ATP binding cassette transporters and drug resistance in breast cancer

  2003cites this paper
• Evolutionary malignant resistance of cells to damaging factors as common biological defence mechanism in neoplastic development. Review of conception.

  2000cites this paper
• P-glycoprotein, metallothionein and NM23 protein expressions in breast carcinoma.

  2000cites this paper
• Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.

  1998cites this paper
• Phorbol ester-induced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line.

  1998cites this paper
• Regulation of the MDR1 promoter by cyclic AMP-dependent protein kinase and transcription factor Sp1.

  1998cites this paper
• [Detection of metastatic activity of the MCF-7 multidrug resistant cell line cultured in spheroids].

  1998cites this paper
• French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours

  1997cites this paper
• Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

  1997cites this paper
• mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy

  1997cites this paper
• New strategies in locally advanced breast cancer.

  1997cites this paper
• Alterations of vinblastine influx in multidrug-resistant lymphoblastic leukaemic CEM cells.

  1996cites this paper
• MDR1 gene expression: evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas.

  1996cites this paper
• Critical evaluation of prognostic factors.

  1996cites this paper
• Anthracycline resistance in breast cancer: clinical applications of current knowledge.

  1995cites this paper
• Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs.

  1994cites this paper
• [Drug resistance: from the laboratory to the clinic. Variations in drug resistance with time].

  1994cites this paper
• [The multidrug resistance phenotype: some morphological and biological characteristics except efflux pump].

  1994cites this paper
• Intrinsic or acquired drug resistance and metastasis: Are they linked phenotypes?

  1994cites this paper